Screener
Praxis Precision Medicines, Inc. PRAX Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The source filing: Praxis Precision Medicines, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 9:06 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001689548-26-000047
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Purchases of property and equipment | (62) | — |
| Purchases of marketable securities | (486,782) | (117,057) |
| Maturities of marketable securities | 142,569 | 65,993 |
| Net cash used in investing activities | (344,275) | (51,064) |
| Cash flows from financing activities: | ||
| Issuance of common stock from follow-on public offering, net of underwriting discounts, commissions and offering costs | 621,235 | — |
| Proceeds from at-the-market offerings, net of issuance and commission costs | — | 54,904 |
| Payments of tax withholdings related to vesting of restricted stock units | (12,923) | (1,195) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Praxis Precision Medicines, Inc.'s investing cash flow?
- Praxis Precision Medicines, Inc. (PRAX) reported investing cash flow of -$344.28M in Q1 2026.
- How has Praxis Precision Medicines, Inc.'s investing cash flow changed year-over-year?
- Praxis Precision Medicines, Inc.'s investing cash flow decreased by 574.2% year-over-year, from -$51.06M to -$344.28M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.
Ask your AI about Praxis Precision Medicines, Inc.'s investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude